We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Geoffrey is a Managing Director and leads the Healthcare Equity Capital Markets practice at Wells Fargo Securities, where he focuses on advising private and public healthcare companies on the strategy and execution of equity and equity-linked financing transactions.
Geoffrey has raised more than $75.0 billion in equity and equity-linked securities in more than 400 transactions during his 17 year career. Before joining Wells Fargo, Geoffrey was a Director at Lazard, where he was a founding member of the Alternative Capital Finance group. He joined Lazard from Cowen and Company, where he was a Vice President in the Private Equity group, executing private equity and PIPE transactions.
Prior to Cowen, Geoffrey worked as a consultant to the Pentagon’s Defense Advanced Research Project Agency (DARPA), where he was involved in the development and management of advanced research programs.
Geoffrey earned a B.A. in mechanical engineering from Johns Hopkins University, an M.E. in engineering from the University of Maryland, and an M.B.A. from Cornell University Johnson School of Management.
This speaker's sessions: